University of Michigan Mott Children's Hospital
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schumacher, Kurt R
FUEL-2, NCT05918211: Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

Recruiting
3
436
US, RoW
Udenafil, Placebo
Mezzion Pharma Co. Ltd
Single Ventricle Heart Disease
10/25
10/25
PLATyPuS, NCT02315898: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Completed
2
40
US
Treatment-inhaled tPA, alteplase, Activase
University of Michigan, Genentech, Inc.
Plastic Bronchitis, Protein-Losing Enteropathies, Healthy
03/21
06/23
FALD, NCT03430583: Evaluation of Fontan-Associated Liver Disease

Active, not recruiting
N/A
100
Canada, US
MZ101
Mezzion Pharma Co. Ltd, National Heart, Lung, and Blood Institute (NHLBI)
Single Ventricle Heart Disease
06/21
08/21
NCT03322345: Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy

Enrolling by invitation
N/A
24
US
University of Michigan
Dopamine, Protein-Losing Enteropathies, Lymphatic System, Lymph, Catecholamine, Single-ventricle, Congenital Heart Disease
04/25
04/25
Sagi, Janaki
PLATyPuS, NCT02315898: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Completed
2
40
US
Treatment-inhaled tPA, alteplase, Activase
University of Michigan, Genentech, Inc.
Plastic Bronchitis, Protein-Losing Enteropathies, Healthy
03/21
06/23
Stringer, Kathleen A
PLATyPuS, NCT02315898: Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis

Completed
2
40
US
Treatment-inhaled tPA, alteplase, Activase
University of Michigan, Genentech, Inc.
Plastic Bronchitis, Protein-Losing Enteropathies, Healthy
03/21
06/23

Download Options